First Edition of EuroBiO 2006 Paris Surpasses Estimates.Next International Congress of Biotechnologies Paris, EuroBiO 2008, Will be held in 2008 PARIS -- "Palais des CongrE s" conference center in Paris - Axel Kahn Axel Kahn, born in 1944, is a French scientist and geneticist. He is the brother of the journalist Jean-François Kahn. He was a member of the French National Consultative Ethics Committee from 1992 to 2004 and worked in gene therapy. , President of EuroBiO 2006, and Eric Poincelet, Commissioner General of EuroBiO 2006 (www.eurobio2006.com), announce successful attendance on EuroBiO 2006, Paris, with almost 5,000 attendees from 23 countries including Malaysian and Brazil delegations! EuroBiO 2006 will close this afternoon, Friday October 27th with keynote speakers Ellis Rubinstein, President, the New York Academy of Sciences The New York Academy of Sciences is the third oldest scientific society in the United States. An independent, non-profit organization with more than 25,000 members in 140 countries, the Academy’s mission is to advance understanding of science and technology. and former editor in Chief, AAAS/Science; Jim Greenwood, President BIO; and Philippe Archinard, Chairman, France Biotech France Biotech is the French trade association of biotechnology companies. It was created in 1997 by a group of French biotechnology entrepreneurs, among whom was its first president Pascal Brandys. , who will be capping three days articulated around four axes axes [L., Gr.] plural of axis. The straight lines which intersect at right angles and on which graphs are drawn. Usually the horizontal axis is the x-axis and the vertical one the y-axis. Called also axes of reference. - an exhibition, a conference, a business convention and a career fair - highlighting the domains of sciences, business, health and politics. "We are extremely pleased to announce that EuroBiO 2006 was a great success. We achieved our main objective: showcase the European ambitions in biotechnology and the contribution of this industry in global economic growth and employment," says Eric Poincelet, Commissioner General. "Biotechnologies are already providing improvements in terms of health and will lead to unprecedented new tools to strengthen environmental protection - through the use of bio-fuels and alternative energies, biochemistry biochemistry, science concerned chiefly with the chemistry of biological processes; it attempts to utilize the tools and concepts of chemistry, particularly organic and physical chemistry, for elucidation of the living system. , biomaterials, etcC*". "We will continue increasing public awareness about health and environment's issues "concludes Eric Poincelet. EuroBiO 2006 in some figures: * The conference attracted 202 high-caliber speakers whose 3/4 were international and participated in 40 symposia sym·po·si·a n. A plural of symposium. , round-tables, and plenary sessions Plenary session is a term often used in s to define the part of the conference when all members of all parties are in attendance. These sessions may contain a broad range of content from Keynotes to Panel Discussions and are not necessarily related to a specific style of delivery. * Within 2,500 square feet net, the exhibition hall welcome: * over 764 companies, organizations, and institutions representing every biotechnology field, who attracted 2,225 visitors * 250 booths including 18 countries and 12 French regions * The Business Convention welcomed over 252 companies and 300 professionals who participated in 1000 one-to-one pre-arranged meetings in one day and a half. * The Career Fair attracted 63 HRDs who met with 220 young professionals * One hundred registered international editors * National and international bioclusters * Federations and industry bodies * Multinationals * Research organizations from around the world * Patient associations Next EuroBiO Paris will be held in 2008 and will be called EuroBiO 2008. EuroBiO 2007, next year, will be held in Lille on September 26, 27, and 28 2007. For the press: Pictures, slides, and abstracts are available on the EuropaBiO web site on www.europabio2006.com About EuroBiO In 2006, the European Biotech bi·o·tech n. Informal Biotechnology. biotech Noun short for biotechnology Noun 1. Crossroads took place in Paris for its 10th anniversary and adopted the name "EuroBiO". EuroBiO is an international event, with a prime focus on European issues and dedicated to biotech's four major fields of application - industry, health, environment and food sectors. Founded in 1997 on the initiative of the French Ministry of Research, the European Biotech Crossroads has succeeded in bringing together all the biotechnology actors: life science companies, start-up projects, students, researchers, private & public-sector research organizations, industry bodies, investors, consulting firms Noun 1. consulting firm - a firm of experts providing professional advice to an organization for a fee consulting company business firm, firm, house - the members of a business organization that owns or operates one or more establishments; "he worked for a , multinationals from the biotech, pharmaceutical, diagnostics, agrifood & environmental sectors, local authorities, clusters, bioparks, bioincubators, public authorities and regulatory bodies. Organization of the European Biotech Crossroads was attributed to (i) the city of Lille and the EurasantE[umlaut umlaut (  m`lout) [Ger.,=transformed sound], in inflection, variation of vowels of the type of English man to men. ] cluster for the 2005 edition and the odd-numbered years to come and (ii) Paris, its Regional Economic Development Agency for Paris Ile-de-France (ARD Ard (ärd), in the Bible.1 Son of Benjamin. 2 Benjamite, perhaps the same as (1.) An alternate form is Addar. ) and their partners for the even-numbered years from 2006 on. For more detailed information, visit the EuroBiO 2006 web site at: www.eurobio2006.com "EuroBiO". |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion